Zusammenfassung
Erkrankungen des endokrinen Systems gehören zu den häufigsten Folgen onkologischer Erkrankungen im Kindes- und Jugendalter. Große Langzeitnachsorgestudien zeigen, dass jeder zweite Überlebende einer Krebserkrankung im Kindesalter im Verlauf des Lebens von mindestens einer endokrinologischen Störung erkrankt, die als direkte Spätfolge auf die antineoplastische Therapie (insbesondere Radiotherapie und Chemotherapie mit Alkylanzien) zurückzuführen ist. Endokrinologische Spätfolgen umfassen Störungen der hypothalamohypophysären Funktion, der Schilddrüse, der Gonaden, des Knochenstoffwechsels bis hin zu einem erhöhten Risiko für die Entwicklung von Adipositas und Diabetes mellitus Typ 2. Nur durch eine systematische, an das individuelle, durch Grunderkrankung und therapeutische Expositionen bestimmte Risiko angepasste, lebenslange Nachsorge können endokrinologische Spätfolgen frühzeitig diagnostiziert, therapiert und so schwerwiegende Beeinträchtigungen von Gesundheit und Lebensqualität der betroffenen Patienten vermieden werden.
Literatur
CA55727 U (2008) Childhood cancer survivor study, baseline data. Based on data posted to CCSS. www.stjude.org/ccss. Zugegriffen am 14.09.2016
Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA (2006) Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 91:1723–1728
Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, Barnes N, Armstrong GT, Krasin MJ, Srivastava DK, Pui CH, Merchant TE, Kun LE, Gajjar A, Hudson MM, Robison LL, Sklar CA (2015) Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study. J Clin Oncol 33:492–500
Chemaitilly W, Merchant TE, Li Z, Barnes N, Armstrong GT, Ness KK, Pui CH, Kun LE, Robison LL, Hudson MM, Sklar CA, Gajjar A (2016) Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes. Clin Endocrinol 84:361–371
Corsello SM, Barnabei A, Marchetti P, De Vecchis L, Salvatori R, Torino F (2013) Endocrine side effects induced by immune checkpoint inhibitors. J Clin Endocrinol Metab 98:1361–1375
Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM (2003) The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 88:95–102
Denzer C, Brabant G, Brämswig J, Dörffel W, Dörr HG, Hauffa BP, Langer T, Müller H, Ott-Renzer C, Wabitsch M (2014) Endokrinologische Nachsorge nach onkologischen Erkrankungen im Kindes- und Jugendalter. AWMF-Leitlinien-Register 025-030
Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494–3498
Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:3888–3921
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Donaldson SS, Byrne J, Robison LL (2009a) Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 27:2677–2685
Green DM, Sklar CA, Boice JDJ, Mulvihill JJ, Whitton JA, Stovall M, Yasui Y (2009b) Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol 27:2374–2381
Hauffa BP, Simic-Schleicher G (2011) Pubertas tarda und Hypogonadismus. AWMF-Leitlinien-Register 027-025
Hewitt M, Weiner SL, JV S (Hrsg) (2003) Childhood cancer survivorship: improving care and quality of life. National Academies Press, Washington, DC
Kaatsch P, Grabow D (2012) The German cohort of long-term survivors of childhood cancer. A population-based cohort in the German Childhood Cancer Registry. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55:843–851
Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN (2003) Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88:5307–5314
Meistrich ML (2013) Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril 100:1180–1186
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582
Patterson BC, Chen Y, Sklar CA, Neglia J, Yasui Y, Mertens A, Armstrong GT, Meadows A, Stovall M, Robison LL, Meacham LR (2014) Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 99:2030–2037
Rose SR, Horne VE, Howell J, Lawson SA, Rutter MM, Trotman GE, Corathers SD (2016) Late endocrine effects of childhood cancer. Nat Rev Endocrinol. 12(6):319–36. https://doi.org/10.1038/nrendo.2016.45
Sfeir JG, Kittah NEN, Tamhane SU, Jasim S, Chemaitilly W, Cohen LE, Murad MH (2018) Diagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers. J Clin Endocrinol Metab. 103(8):2785–2793
Sklar C, Sarafoglou K, Whittam E (1993) Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol 129:511–515
Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL (2002) Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87:3136–3141
Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M (2000) Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356:993–997
Wabitsch M, Kunze D (2015) Konsensbasierte (S2) Leitlinie zur Diagnostik, Therapie und Prävention von Übergewicht und Adipositas im Kindes- und Jugendalter. Version 2015
Wabitsch M, Moß A, Hauner H, Kromeyer-Hauschild K, Kunze D, Reinehr T, Tafel J, Wiegand S (2009) Therapie der Adipositas im Kindes- und Jugendalter. AWMF-Leitlinien-Register 050-002
Wei C, Thyagiarajan M, Hunt L, Cox R, Bradley K, Elson R, Hamilton-Shield J, Stevens M, Crowne E (2015a) Reduced beta-cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation. Clin Endocrinol 82:59–67
Wei C, Thyagiarajan MS, Hunt LP, Shield JP, Stevens MC, Crowne EC (2015b) Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes. Pediatr Blood Cancer 62:1992–1999
Zhang FF, Kelly MJ, Saltzman E, Must A, Roberts SB, Parsons SK (2014) Obesity in pediatric ALL survivors: a meta-analysis. Pediatrics 133:e704–e715
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Denzer, C., Langer, T. (2018). Endokrinologische Langzeitfolgen in der pädiatrischen Onkologie. In: Hiort, O., Danne, T., Wabitsch, M. (eds) Pädiatrische Endokrinologie und Diabetologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-52794-8_9-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-52794-8_9-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-52794-8
Online ISBN: 978-3-662-52794-8
eBook Packages: Springer Referenz Medizin